Literature DB >> 2479559

Evidence for immunological differences between circulating and thyroid tissue-derived thyroglobulin in men.

R Schulz1, H Bethäuser, L Stempka, B Heilig, A Moll, M Hüfner.   

Abstract

The expression of six antigenic epitopes on plasma Tg and tissue-derived Tg was investigated using mouse mabs in immunoradiometric assays. The sensitivity of the assays ranged between 0.5 and 1.5 micrograms l-1. Plasma thyroglobulin of 15 normal individuals and 18 patients with metastatic, differentiated thyroid cancer was analysed. Whereas five monoclonals produced values comparable to the conventional RIA system, the monoclonal antibody Tg 158 did not detect any Tg in the normal individuals and only low levels in two of the cancer patients with the highest Tg levels. In contrast, dilutions of extracts of three different euthyroid goitre samples and three different samples of differentiated thyroid cancer revealed no difference in the antigenic expression of all six epitopes, including the Tg 158 epitope. Papain digestion of purified Tg resulted in a 76 kD fragment which showed immunoreactivity for Tg 158 as well as for Tg 11. No interference of the binding of Tg 158 by T3, T4 or DIT could be detected. We conclude that the monoclonal antibody Tg 158 detects an epitope which is present in thyroid tissue-derived Tg but not in circulating thyroglobulin. This antibody might be useful for the investigation of the secretory process of thyroglobulin from the thyrocytes into the circulation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2479559     DOI: 10.1111/j.1365-2362.1989.tb00259.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  7 in total

Review 1.  Thyroglobulin as a biomarker of iodine deficiency: a review.

Authors:  Zheng Feei Ma; Sheila A Skeaff
Journal:  Thyroid       Date:  2014-06-12       Impact factor: 6.568

2.  Biochemical persistence in thyroid cancer: is there anything to worry about?

Authors:  Fabián Pitoia; Pitoia Fabián; Erika Abelleira; Abelleira Erika; Hernán Tala; Tala Hernán; Fernanda Bueno; Bueno Fernanda; Carolina Urciuoli; Urciuoli Carolina; Graciela Cross; Cross Graciela
Journal:  Endocrine       Date:  2013-11-28       Impact factor: 3.633

3.  Comparison of the influence of thyroglobulin antibodies on serum thyroglobulin values from two different immunoassays in post surgical differentiated thyroid carcinoma patients.

Authors:  Marijana Stanojevic; Svetlana Savin; Dubravka Cvejic; Aleksandar Djukic; Marija Jeremic; Snezana Zivancević Simonovic
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

4.  Thyroglobulin-reactive T lymphocytes in thyroiditis-prone BB/Wor rats.

Authors:  E M Allen; J N Thupari
Journal:  J Endocrinol Invest       Date:  1995-01       Impact factor: 4.256

5.  Recurrent/metastatic thyroid carcinomas false negative for serum thyroglobulin but positive by posttherapy I-131 whole body scans.

Authors:  Eun-Kyung Park; June-Key Chung; Il Han Lim; Do Joon Park; Dong Soo Lee; Myung Chul Lee; Bo Youn Cho
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-09-09       Impact factor: 9.236

6.  Definition of the upper reference limit for thyroglobulin antibodies according to the National Academy of Clinical Biochemistry guidelines: comparison of eleven different automated methods.

Authors:  F D'Aurizio; P Metus; A Ferrari; B Caruso; R Castello; D Villalta; A Steffan; K Gaspardo; F Pesente; N Bizzaro; E Tonutti; S Valverde; C Cosma; M Plebani; R Tozzoli
Journal:  Auto Immun Highlights       Date:  2017-06-19

7.  Impact of Thyroglobulin and Thyroglobulin Antibody Assay Performance on the Differential Classification of DTC Patients.

Authors:  Lise Schoonen; Marjolein Neele; Hans van Toor; Caroline M J van Kinschot; Charlotte van Noord; W Edward Visser; Joost Groen; Lianne S M Boesten; Eef G W M Lentjes; Sjoerd A A van den Berg; Snjezana Kos
Journal:  J Endocr Soc       Date:  2021-11-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.